Related Experiment Video
Updated: Jun 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention
Kosmas I Paraskevas1, Ioannis Kotsikoris, Sotirios A Koupidis
1Department of Vascular Surgery, Red Cross Hospital, 24, Al. Papagou Street, Athens, Greece. paraskevask@hotmail.com
Insights
Cardiovascular disease is a major concern for dialysis patients. Managing traditional and non-traditional risk factors is crucial for preventing cardiovascular events and improving survival rates in this population.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in patients with chronic kidney disease (CKD) undergoing dialysis (peritoneal dialysis/hemodialysis).
- Effective vascular disease prevention strategies are vital to mitigate cardiovascular events and reduce high morbidity and mortality rates in this vulnerable patient group.
Discussion:
- This editorial examines traditional risk factors for CVD in renal patients, including smoking, dyslipidemia, body mass index, glycemic control, and blood pressure.
- It also addresses non-traditional risk factors such as anemia, vitamin D deficiency/hyperparathyroidism, calcium/phosphorus metabolism imbalances, and magnesium levels.
Key Insights:
- Current scientific evidence does not advocate for the routine use of statins or antiplatelet medications in dialysis patients.
- Patient compliance and adherence to recommended preventive measures are paramount for reducing cardiovascular events and mortality.
Outlook:
- Future research should focus on personalized risk factor management and novel therapeutic strategies for CVD prevention in dialysis patients.
- Emphasis on patient education and multidisciplinary care approaches may enhance adherence and improve long-term cardiovascular outcomes.
Abstract:
Cardiovascular disease is the leading cause of death in both chronic kidney disease and peritoneal dialysis/hemodialysis patients. Vascular disease prevention in these patients is therefore important to reduce the incidence of cardiovascular events and the high morbidity and mortality. This Editorial discusses the traditional, (1) smoking, (2) dyslipidemia, (3) body mass index, (4) glycemic control and (5) blood pressure, and non-traditional, (1) anemia, (2) vitamin D/hyperparathyroidism, (3) calcium/phosphorus metabolism and (4) magnesium, risk factors in renal patients. Current evidence does not support routine statin use and antiplatelet medication to dialysis patients. Patient compliance and adherence to proposed measures could be essential to reduce cardiovascular events and mortality rates in this high-risk population.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease I: Introduction
